BlueCrest Capital Management’s Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 GLS.WS Stock Holding History

BlueCrest Capital Management’s Portfolio GLS.WS Stock Details GLS.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57,500,000	Closed	-$5.12K	–	323
2022 Q4	$5.12K	Buy	57,500,000 +56,925,000	+9,900%	+$1.13M	﹤0.01%	148
2022 Q3	$29K	Hold	575,000	–	–	﹤0.01%	165
2022 Q2	$60K	Hold	575,000	–	–	﹤0.01%	168
2022 Q1	$129K	Buy	+575,000	New	+$134K	﹤0.01%	253

Other funds holding GLS.WS

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

FIG

Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

BlueCrest Capital Management's GLS.WS Position: Q1 2023 in Review

BlueCrest Capital Management sold out of Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (GLS.WS) in Q1 2023, closing a stake of 57,500,000 shares — an estimated $5.12K sold.

BlueCrest Capital Management first reported a position in GLS.WS in Q1 2022 and held it in 4 quarters. The position peaked at $129K in Q1 2022. 4 funds tracked by Wall St. Rank hold GLS.WS as of Q1 2023.

BlueCrest Capital Management reported no remaining Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
BlueCrest Capital Management sold 57,500,000 Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q1 2023, an estimated $5.12K.
BlueCrest Capital Management first reported a position in Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 4 quarters.
BlueCrest Capital Management's Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $129K in Q1 2022.
4 funds tracked by Wall St. Rank held Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q1 2023.

Based on BlueCrest Capital Management's 13F filing for Q1 2023, filed 15 May 2023.